The pathogenic variants of TNNI3K have been associated with a spectrum of cardiac conditions, including dilated cardiomyopathy, atrial fibrillation, and conduction system diseases (Gan et al., 2019; Theis et al., 2014). Here, TNNI3K is linked to atrial fibrillation.